emendrix

Art. 383

Capital Requirements Regulation · 32013R0575 · every event for this act · on EUR-Lex

Standardised approach

4 changes recorded across 4 events, newest first.

in force 2025-01-01 MODIFIED+3,300 −8,117

Amended by Regulation (EU) 2024/1623 32024R1623 · Regulation (EU) 2024/2987 32024R2987 · Regulation (EU) 2024/2795 32024R2795

applies from: unknown (the text changed beyond its dates, so no date that moved can be read as the application date)

dates removed: 2014-01-01

The provision was renamed from 'Advanced method' to 'Standardised approach' and its entire content was replaced: the earlier version set out a detailed internal-model formula for calculating CVA own funds requirements based on credit spreads, expected exposure and discount factors, while the new version instead sets out permission requirements an institution must satisfy for competent authority approval to use a standardised approach, defines risk classes and CVA portfolio terms, and states that own funds requirements are the sum of delta risk and vega risk requirements calculated under Article 383b.

The prior seven paragraphs covering the advanced internal model, its formulae, margined trading treatment, IMM permission provisions, stressed value-at-risk calculation, proxy spread handling, and EBA regulatory technical standards have all been removed and replaced with three new paragraphs referencing newly introduced Articles 383a, 383b, 383i and 383j.

Cited: Art. 383, v1 · Art. 383, v2

text before / after

texts differ too much for an inline diff; shown separately

before (02013R0575-20240709)

Article 383
Advanced method
1. An institution which has permission to use an internal model for the specific risk of debt instruments in accordance with point (d) of Article 363 (1) shall, for all transactions for which it has permission to use the IMM for determining the exposure value for the associated counterparty credit risk exposure in accordance with Article 283, determine the own funds requirements for CVA risk by modelling the impact of changes in the counterparties' credit spreads on the CVAs of all counterparties of those transactions, taking into account CVA hedges that are eligible in accordance with Article 386.
An institution shall use its internal model for determining the own funds requirements for the specific risk associated with traded debt positions and shall apply a 99 % confidence interval and a 10-day equivalent holding period. The internal model shall be used in such way that it simulates changes in the credit spreads of counterparties, but does not model the sensitivity of CVA to changes in other market factors, including changes in the value of the reference asset, commodity, currency or interest rate of a derivative.
The own funds requirements for CVA risk for each counterparty shall be calculated in accordance with the following formula:CVALGDMKT  Ti1 max 0,exp  si  1  ti  1LGDMKT exp  si  tiLGDMKT  EEi  1  Di  1 EEi  Di2
where:
ti
the time of the i-th revaluation, starting from t0=0;
tT
the longest contractual maturity across the netting sets with the counterparty;
si
is the credit spread of the counterparty at tenor ti, used to calculate the CVA of the counterparty. Where the credit default swap spread of the counterparty is available, an institution shall use that spread. Where such a credit default swap spread is not available, an institution shall use a proxy spread that is appropriate having regard to the rating, industry and region of the counterparty;
LGDMKT
the LGD of the counterparty that shall be based on the spread of a market instrument of the counterparty if a counterparty instrument is available. Where a counterparty instrument is not available, it shall be based on the proxy spread that is appropriate having regard to the rating, industry and region of the counterparty.
The first factor within the sum represents an approximation of the market implied marginal probability of a default occurring between times ti-1 and ti;
EEi
the expected exposure to the counterparty at revaluation time ti, where exposures of different netting sets for such counterparty are added, and where the longest maturity of each netting set is given by the longest contractual maturity inside the netting set; An institution shall apply the treatment set out in paragraph 3 in the case of margined trading, if the institution uses the EPE measure referred to in point (a) or (b) of Article 285(1) for margined trades;
Di
the default risk-free discount factor at time ti, where D0 =1.
2. When calculating the own funds requirements for CVA risk for a counterparty, an institution shall base all inputs into its internal model for specific risk of debt instruments on the following formulae (whichever is appropriate):
(a) where the model is based on full repricing, the formula in paragraph 1 shall be used directly;
(b) where the model is based on credit spread sensitivities for specific tenors, an institution shall base each credit spread sensitivity ('Regulatory CS01') on the following formula:
Regulatory CS01i0.0001  ti  exp  si  tiLGDMKT  EEi  1  Di  1  EEi  1  Di  12
For the final time bucket i=T, the corresponding formula is
Regulatory CS01T0.0001  tT  expsT  tTLGDMKT  EET  1  DT  1 EET  DT2
(c) where the model uses credit spread sensitivities to parallel shifts in credit spreads, an institution shall use the following formula:
Regulatory CS01 0.0001  Ti1ti  expsi  tiLGDMKT  ti  1  expsi  1  ti  1LGDMKT  EEi  1  Di  1EEi  Di2
(d) where the model uses second-order sensitivities to shifts in credit spreads (spread gamma), the gammas shall be calculated based on the formula in paragraph 1.
3. An institution using the EPE measure for collateralised OTC derivatives referred to in point (a) or (b) of Article 285(1) shall, when determining the own funds requirements for CVA risk in accordance with paragraph 1, do both of the following:
(a) assume a constant EE profile;
(b) set EE equal to the effective expected exposure as calculated under Article 285(1)(b) for a maturity equal to the greater of the following:
(i) half of the longest maturity occurring in the netting set;
(ii) the notional weighted average maturity of all transactions inside the netting set.
4. An institution which is permitted by the competent authority in accordance with Article 283 to use IMM to calculate exposure values in relation to the majority of its business, but which uses the methods set out in Section 3, Section 4 or Section 5 of Title II, Chapter 6 for smaller portfolios, and which has permission to use the market risk internal model for the specific risk of debt instruments in accordance with point (d) of Article 363(1) may, subject to permission from the competent authorities, calculate the own funds requirements for CVA risk in accordance with paragraph 1 for the non-IMM netting sets. Competent authorities shall grant this permission only if the institution uses the methods set out in Section 3, Section 4 or Section 5 of Title II, Chapter 6 for a limited number of smaller portfolios.
For the purposes of a calculation under the preceding subparagraph and where the IMM model does not produce an expected exposure profile, an institution shall do both of the following:
(a) assume a constant EE profile;
(b) set EE equal to the exposure value as computed under the methods set out in Section 3, Section 4 or Section 5 of Title II, Chapter 6, or IMM for a maturity equal to the greater of:
(i) half of the longest maturity occurring in the netting set;
(ii) the notional weighted average maturity of all transactions inside the netting set.
5. An institution shall determine the own funds requirements for CVA risk in accordance with Article 364(1) and Articles 365 and 367 as the sum of non-stressed and stressed value-at-risk, which shall be calculated as follows:
(a) for the non-stressed value-at-risk, current parameter calibrations for expected exposure as set out in the first subparagraph of Article 292(2), shall be used;
(b) for the stressed value-at-risk, future counterparty EE profiles using a stressed calibration as set out in the second subparagraph of Article 292(2) shall be used. The period of stress for the credit spread parameters shall be the most severe one-year stress period contained within the three-year stress period used for the exposure parameters;
(c) the three-times multiplication factor used in the calculation of own funds requirements based on a value-at-risk and a stressed value-at-risk in accordance with 364(1) will apply to these calculations. EBA shall monitor for consistency any supervisory discretion used to apply a higher multiplication factor than that three-times multiplication factor to the value-at-risk and stressed value-at-risk inputs to the CVA risk charge. Competent authorities applying a multiplication factor higher than three shall provide a written justification to EBA;
(d) the calculation shall be carried out on at least a monthly basis and the EE that is used shall be calculated on the same frequency. If lower than a daily frequency is used, for the purpose of the calculation specified in points (a)(ii) and (b)(ii) of Article 364(1) institutions shall take the average over three months.
6. For exposures to a counterparty, for which the institution's approved internal model for the specific risk of debt instruments does not produce a proxy spread that is appropriate with respect to the criteria of rating, industry and region of the counterparty, the institution shall use the method set out in Article 384 to calculate the own funds requirement for CVA risk.
7. EBA shall develop draft regulatory technical standards to specify in greater detail:
(a) how a proxy spread is to be determined by the institution's approved internal model for the specific risk of debt instruments for the purposes of identifying si and LGDMKT referred to in paragraph 1;
(b) the number and size of portfolios that fulfil the criterion of a limited number of smaller portfolios referred to in paragraph 4.
EBA shall submit those draft regulatory technical standards to the Commission by 1 January 2014.
Power is delegated to the Commission to adopt the regulatory technical standards referred to in the first subparagraph in accordance with Articles 10 to 14 of Regulation (EU) No 1093/2010.

after (02013R0575-20250101)

Article 383
Standardised approach
1. The competent authority shall grant an institution permission to calculate its own funds requirements for CVA risk for a portfolio of transactions with one or more counterparties by using the standardised approach in accordance with paragraph 3 of this Article, after having assessed whether the institution complies with the following requirements:
(a) the institution has established a distinct unit which is responsible for the institution’s overall risk management and hedging of CVA risk;
(b) for each counterparty concerned, the institution has developed a regulatory CVA model to calculate the CVA of that counterparty in accordance with Article 383a;
(c) for each counterparty concerned, the institution is able to calculate, at least on a monthly basis, the sensitivities of its CVA to the risk factors concerned as determined in accordance with Article 383b;
(d) for all positions in eligible hedges recognised in accordance with Article 386 for the purpose of calculating the own funds requirements for CVA risk using the standardised approach, the institution is able to calculate, and at least on a monthly basis, the sensitivities of those positions to the relevant risk factors determined in accordance with Article 383b;
(e) the institution has established a risk control unit that is independent from business trading units and the unit referred to in point (a) and that reports directly to the management body; that risk control unit shall be responsible for designing and implementing the standardised approach and shall produce and analyse monthly reports on the output of that approach and, moreover, the risk control unit shall assess the appropriateness of the institution’s trading limits and include the results of that assessment in its monthly reports; the risk control unit shall have a sufficient number of staff with a level of skills that is appropriate to fulfil its purpose.
For the purposes of the first subparagraph, point (c), of this paragraph the sensitivity of a counterparty’s CVA to a risk factor means the relative change in the value of that CVA, as a result of a change in the value of one of the relevant risk factors of that CVA, calculated using the institution’s regulatory CVA model in accordance with Articles 383i and 383j.
For the purposes of the first subparagraph, point (d), of this paragraph the sensitivity of a position in an eligible hedge to a risk factor means the relative change in the value of that position, as a result of a change in the value of one of the relevant risk factors of that position, calculated using the institution’s pricing model in accordance with Articles 383i and 383j.
2. For the purpose of calculating the own funds requirements for CVA risk, the following definitions apply:
(1) risk class means any of the following categories:
(a) interest rate risk;
(b) counterparty credit spread risk;
(c) reference credit spread risk;
(d) equity risk;
(e) commodity risk;
(f) foreign exchange risk;
(2) CVA portfolio means the portfolio composed of the aggregate CVA and the eligible hedges referred to in paragraph 1, point (d);
(3) aggregate CVA means the sum of the CVAs calculated using the regulatory CVA model for the counterparties referred to in paragraph 1, first subparagraph.
3. Institutions shall determine the own funds requirements for CVA risk using the standardised approach as the sum of the following own funds requirements calculated in accordance with Article 383b:
(a) the own funds requirements for delta risk which capture the risk of changes in the institution’s CVA portfolio due to movements in the relevant non-volatility related risk factors;
(b) the own funds requirements for vega risk which capture the risk of changes in the institution’s CVA portfolio due to movements in the relevant volatility related risk factors.

in force 2024-07-09 MODIFIED

Amended by Regulation (EU) 2024/1623 32024R1623

applies from: unknown

Sources disagree — the amending act's instructions found this change; the text comparison finds no difference in the provision's text and the EU's own amendment metadata does not list it. All are shown; none is overruled.

No explanation shipped — the structural diff did not see this change, so it carries no text; another signal named the unit and the disagreement ships as `disputed`.

text before / after, on the event page →

in force 2015-01-18 MODIFIED

Amended by Regulation (EU) 2015/62 32015R0062 · Regulation (EU) 2018/405 32018R0405

applies from: unchanged

Sources disagree — the text comparison found this change; the EU's own amendment metadata does not list it. Both are shown; neither is overruled.

The formulae in paragraphs 1 and 2 for calculating own funds requirements for CVA risk have been reformatted, with mathematical symbols and operators rendered differently, though the underlying variables and structure described in the surrounding text remain the same.

The paragraph numbering style throughout Article 383 was changed so that numbered paragraphs no longer begin on a separate line but run directly into the following text.

Cited: Art. 383, v1 · Art. 383, v2

text before / after, on the event page →

detected 2026-08-13 MODIFIED

no amending act named

applies from: unchanged

The label used for the formula input in paragraph 2(b), previously written as Regulatory CS01, is now enclosed in quotation marks as 'Regulatory CS01'.

In paragraph 5 and its points (a) to (c), the terms Value-at-Risk and multiplier are replaced with value-at-risk and multiplication factor, and the phrase CVA charge is replaced with CVA risk charge.

Paragraph numbering formatting changes such that the numeral of each paragraph now stands on its own line before the paragraph text, rather than being followed directly by the text on the same line.

Cited: Art. 383, v1 · Art. 383, v2

text before / after, on the event page →